MEDVi Pricing Explained: First-Month Rate vs Semaglutide Refill Costs

Last reviewed: September 7, 2026 Last updated: September 7, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

PlexusDx publishes this comparison and is one of the providers discussed. We use the same evidence rules for our own program and competing programs.

The short answer

MEDVi's compounded GLP-1 program uses a two-tier pricing model: a first-month introductory rate followed by a higher refill price. Compounded semaglutide injection costs $179 for the first month (introductory rate), then $299 per refill every four weeks; compounded tirzepatide costs $279 first month (introductory), then $399 per refill. The program includes the initial provider consultation, medication, unlimited support calls, a free dietitian visit, and shipping at no additional charge—no membership fee applies to the compounded pathway. Dose escalation does not change the monthly price. Over a full year, the blended effective cost for semaglutide injection is $289 per month (our calculation: $179 introductory + eleven $299 refills ÷ 12 months). Understanding the gap between introductory and ongoing rates is essential for budgeting multi-month treatment. MEDVi also offers 3-, 6-, and 12-month prepaid bundles with 0% financing available through Klarna, though specific bundle rates were not published in our sources.

At-a-glance pricing comparison

MEDVi pricing captured September 4, 2026; PlexusDx pricing captured September 7, 2026.

Understanding MEDVi's medication cost structure

MEDVi prices compounded semaglutide injection at a first-month introductory rate of $179, followed by a refill rate of $299 per month. Each order covers a four-week supply. The refill price remains constant through dose escalation—moving from 0.25 mg weekly to 2.4 mg weekly does not change the $299 monthly charge. Over a full year, a patient pays $179 in month one and $299 for each of the eleven subsequent months, totaling $3,468 (our calculation). Divided by twelve, that yields an effective monthly cost of $289.

Compounded tirzepatide follows the same two-tier model: $279 first month, $399 per refill, for a year-one total of $4,668 and an effective monthly rate of $389 (our calculation). MEDVi offers tirzepatide in both injection and oral capsule form at the same price; semaglutide oral tablets carry a $70 surcharge over the injection route, putting the first month at $249 and refills at $369.

MEDVi also maintains a separate branded medication pathway (Wegovy, Zepbound) that requires a $99 monthly membership; medication cost is additional and was not captured at checkout in our research. The remainder of this article focuses on the compounded program, which carries no membership fee.

What's included at each price tier

The compounded monthly rate bundles medication, the initial clinician consultation, unlimited follow-up support calls, a complimentary dietitian visit, and shipping. No separate lab fee, visit fee, or membership charge applies. MEDVi describes the support infrastructure as "care coaching" with unlimited access to doctors; patients can initiate a call anytime during treatment without triggering additional charges. Dose adjustments are handled within the same monthly price, so a patient who begins at the starter dose and escalates to the maintenance dose over six months pays the same $299 refill rate throughout.

MEDVi offers multi-month bundles—3-, 6-, and 12-month prepaid packages—with 0% financing available through Klarna over twelve months. MEDVi states it is "not a party" to the financing agreement. Our sources document that these bundles exist and extend to a 48-week term, but specific per-month bundle rates were not published and we do not derive or estimate them. Bundles are characterized as non-refundable for unused months. The monthly-refill option carries no contract and can be canceled at any time.

Comparing first-year cost across month-to-month programs

When a patient commits to a full year of treatment on a month-to-month basis—the most flexible and directly comparable option—the introductory discount affects only the first shipment. The table below shows year-one totals and effective monthly rates for MEDVi and PlexusDx, using only month-to-month pricing with no prepaid commitments (all figures are our calculation):

The introductory rate of $179 for semaglutide saves a patient $120 in the first month compared to PlexusDx's standard $189. That advantage reverses in month two: MEDVi's $299 refill rate is $110 higher than PlexusDx's $189 month-to-month price. Over the remaining eleven months, that $110 monthly gap accumulates to $1,210 (our calculation), erasing the first-month savings and resulting in a net $1,200 higher cost over twelve months. The same dynamic applies to tirzepatide: a $10 first-month advantage ($279 vs. $289) followed by a $110 monthly disadvantage ($399 vs. $289) for eleven refills.

If a patient on MEDVi's monthly plan later decides to pause or stop treatment after six months, the all-in cost through that point would be $179 introductory + (5 × $299 refill) = $1,674 for semaglutide injection (our calculation). The same six months on PlexusDx month-to-month would cost 6 × $189 = $1,134, a difference of $540. The flexibility of month-to-month billing allows a patient to cancel without penalty, but the refill rate determines most of the expense once treatment extends beyond the initial shipment.

PlexusDx commitment tiers and long-term rates

PlexusDx publishes every price tier—month-to-month, 3-month, and 6-month—on the product page before intake begins. The month-to-month rate for compounded semaglutide injection is $189; a patient who selects the 3-month commitment pays $169 per month ($507 every three months), and the 6-month commitment drops the rate to $149 per month ($894 every six months). All three options are flat rates with no introductory period; the price in month one is the price in month twelve.

Over a full year, PlexusDx semaglutide injection costs $2,268 month-to-month, $2,028 on the 3-month tier, or $1,788 on the 6-month tier (our calculation). For tirzepatide, the corresponding totals are $3,468 month-to-month, $3,228 on 3-month, and $2,988 on 6-month. Each tier includes the provider consultation, prescription, compounded medication from a licensed 503A pharmacy, and shipping in one flat charge—no membership fee, no per-visit billing, no dose-escalation surcharge.

PlexusDx also offers a microdose GLP-1 injection protocol at $129 per month, designed for patients seeking maintenance dosing or weight stabilization after reaching goal weight on a full-dose regimen. A free check-in with a Doctor of Pharmacy is included; an optional genetic test is available at $99 for program members (retail $298), though the test does not select or predict which medication a provider will prescribe—prescribing remains a clinical decision.

Decision factors: intro discount vs. ongoing refill rate

The central trade-off in MEDVi's pricing structure is the lower entry cost against the higher recurring expense. A first-month price of $179 for semaglutide injection makes the initial financial commitment smaller than most competitors, which may matter to a patient uncertain about tolerance or response. If a patient experiences significant nausea in the first two weeks and decides not to continue, the out-of-pocket loss is $179 rather than a higher upfront figure or a prepaid multi-month bundle.

That advantage fades quickly. By month three, cumulative spending on MEDVi ($179 introductory + $299 refill + $299 refill = $777, our calculation) overtakes PlexusDx month-to-month ($189 × 3 = $567, our calculation) by $210. At six months, the gap is $540; at twelve months, $1,200. For patients who know they plan to remain on treatment for a year or longer—a common scenario given the intended duration of GLP-1 therapy for weight management—the refill rate becomes the dominant cost driver.

MEDVi's all-inclusive support model—unlimited calls, dietitian visit, dose management—delivers a structured care experience without separate line-item charges. Some patients value scheduled coaching and proactive outreach; others prefer lighter-touch support and prioritize lower medication cost. Neither model is universally superior; the decision depends on whether the added support justifies the higher refill rate in a given patient's situation.

Pricing transparency differs between the two programs. MEDVi displays rates after a patient completes the health questionnaire; PlexusDx publishes every tier on the product page before intake begins. Early price visibility allows a patient to budget and compare before investing time in an intake form. Post-intake pricing may be appropriate when eligibility or medication selection is uncertain, but it shifts the comparison effort later in the process.

When the first-month advantage matters most

MEDVi's introductory pricing structure serves patients in a few specific scenarios. A patient who wants to trial GLP-1 therapy with minimal upfront financial exposure may prefer a $179 first month over a $289 standard rate, knowing the option to cancel exists after the first shipment. A patient with uncertain insurance coverage—waiting for an appeal decision or verifying whether an HSA will reimburse compounded medications—might value the lower initial spend while those questions resolve.

Patients who plan short treatment durations (for example, targeting a specific event three months out) face different economics than those pursuing sustained weight management over one to two years. For a planned 12-week course, total MEDVi cost would be $179 introductory + $299 refill + $299 refill = $777 (our calculation); PlexusDx month-to-month would be $189 × 3 = $567, still $210 lower. The intro discount does not overcome the refill-rate gap even at short durations, but it narrows the difference compared to year-long treatment.

MEDVi's multi-month bundles may offer lower per-month rates than the $299 refill price, and 0% Klarna financing spreads the payment over twelve months without interest. However, our sources did not publish specific bundle rates, and bundles are non-refundable for unused months. A patient who prepays six months and then needs to stop treatment in month four forfeits the value of months five and six. Month-to-month flexibility protects against that risk at the cost of the higher per-shipment rate.

Choose MEDVi if…

MEDVi fits patients who prioritize structured support—unlimited provider calls, a dedicated dietitian visit, and proactive coaching—within the medication cost, and who value a lower first-month financial commitment even if the refill rate runs higher than competing month-to-month programs. The $179 semaglutide entry point makes the initial trial more accessible, and the all-inclusive care model may appeal to patients who want frequent check-ins without worrying about per-visit charges.

If you are considering a multi-month prepaid bundle and prefer 0% financing to manage cash flow, MEDVi offers that structure with Klarna, though specific bundle rates were not available in our research. The branded medication pathway (Wegovy, Zepbound) through MEDVi carries a $99 monthly membership plus separate medication cost; that option may be relevant if insurance covers branded drugs or if you have a clinical reason to prefer FDA-approved formulations, but total cost was not captured at checkout in our sources.

Where PlexusDx fits

PlexusDx makes sense for patients who plan sustained treatment—six months or longer—and want transparent, flat-rate pricing with no introductory tier or refill-rate jump. The month-to-month semaglutide injection rate of $189 is $110 below MEDVi's $299 refill price every month after the first; over a year that difference accumulates to $1,200. The 3-month and 6-month commitment tiers drop the rate further ($169 and $149 per month, respectively), and all tiers are published on the product page before intake begins.

If you want the option to step down to a lower-dose maintenance protocol after reaching your goal weight, PlexusDx offers a microdose GLP-1 injection at $129 per month. The program includes a free pharmacist check-in, and an optional genetic test is available at $99 for members—though the test does not determine your medication; a licensed provider makes that clinical decision. Every PlexusDx tier covers consultation, prescription, compounded medication from a 503A pharmacy, and shipping in one charge, with no membership fee and no separate visit billing.

Methodology and freshness

This article is based on verified checkout sessions and product-page captures performed September 4, 2026 (MEDVi) and September 7, 2026 (PlexusDx), supplemented by earlier comparative research captured July 20, 2026. MEDVi first-month and refill prices—$179/$299 for semaglutide injection, $279/$399 for tirzepatide—were observed at the payment-method entry screen after completing intake to the medication-selection page. The $70 oral-tablet surcharge was confirmed on the same date. PlexusDx pricing was captured from published product pages and cross-checked against earlier verification.

All year-one totals, effective monthly rates, and cumulative cost comparisons in this article are our calculations, derived by summing the verified monthly charges over the stated term. We do not publish promotional codes or perform discount arithmetic to derive unpublished prices. MEDVi's multi-month bundle rates were not available in our sources; we note their existence and financing option but do not estimate per-month equivalents. Where we state a cost difference (for example, "$1,200 higher over twelve months"), that figure is our arithmetic based on the verified monthly rates.

Readers should confirm current pricing, eligibility, medication availability, and cancellation terms at checkout. Compounding pharmacy supply, clinician prescribing decisions, and promotional offers can change between our capture date and your enrollment.

Frequently Asked Questions

Does MEDVi charge a membership fee for compounded GLP-1 medications?

No. MEDVi's compounded semaglutide and tirzepatide programs carry no membership fee; the monthly medication price includes consultation, unlimited support calls, a free dietitian visit, and shipping. MEDVi does charge a $99 monthly membership for its branded medication pathway (Wegovy, Zepbound), with medication cost additional.

How long does MEDVi's introductory price last?

The introductory rate—$179 for semaglutide injection, $279 for tirzepatide—applies only to the first four-week shipment. Every subsequent refill is billed at the standard rate: $299 per month for semaglutide, $399 for tirzepatide. Dose escalation does not change the refill price.

Can I cancel MEDVi after the first month without penalty?

Yes, if you select the month-to-month billing option. MEDVi states "cancel anytime" and imposes no contract on the monthly refill plan. Multi-month prepaid bundles are described as non-refundable for unused months, so a patient who stops treatment mid-bundle forfeits the remaining shipments.

How does MEDVi's refill rate compare to PlexusDx over a full year?

MEDVi's semaglutide refill rate is $299 per month; PlexusDx charges $189 month-to-month, a $110 monthly difference. Over eleven refill months (after the first shipment), that gap totals $1,210. Including MEDVi's lower first month, the net year-one difference is $1,200 in PlexusDx's favor for month-to-month plans.

What is included in MEDVi's monthly medication price?

The monthly charge covers compounded medication, the initial clinician consultation, unlimited follow-up support calls with doctors, one complimentary dietitian visit, and shipping. No separate lab fee, per-visit charge, or dose-escalation surcharge applies. MEDVi describes the support model as "care coaching" with unrestricted access during treatment.

Sources

• MEDVi compounded medication pricing and included services (verified at checkout September 4, 2026)
• MEDVi multi-month bundles and financing options (captured July 20, 2026)
• PlexusDx product-page pricing for semaglutide and tirzepatide injection, oral, and microdose protocols (captured September 7, 2026 and July 20, 2026)
• PlexusDx Trustpilot rating and review distribution (captured September 4, 2026)

Compounded medication disclosure: Compounded medications are not FDA-approved. FDA does not review compounded drugs before marketing for safety, effectiveness, or quality. A licensed clinician determines whether a prescription is appropriate for an individual patient. PlexusDx works with licensed 503A compounding pharmacies.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.